Pharmacological Management of Hereditary Angioedema with C1-Inhibitor Deficiency in Pediatric Patients
- 7 December 2017
- journal article
- review article
- Published by Springer Nature in Pediatric Drugs
- Vol. 20 (2) , 135-151
Abstract
Hereditary angioedema with C1-inhibitor deficiency (C1-INH-HAE) is a form of bradykinin-mediated angioedema. It is a rare disorder with an onset during childhood in most instances. Therefore, familiarity with the options for the management of pediatric cases is indispensable. The recurrent angioedematous episodes do not respond to conventional treatments and may evolve into a life-threatening condition. In view of the recommendations adopted by international consensus in 2016, patient management and follow-up should be guided by an individualized strategy. During the last decade, various medicinal products with novel modes of action and different posology have been developed for the treatment of C1-INH-HAE. These drugs either inhibit the release of bradykinin (plasma-derived C1-inhibitors, recombinant C1-inhibitors, kallikrein inhibitors) or prevent the released bradykinin from binding to its receptor (bradykinin B2 receptor antagonists). This review summarizes the properties of the medicinal products currently available for the treatment of C1-INH-HAE, the indications for their use in pediatric patients, and the findings of the clinical trials conducted in this patient population. It is concluded by a brief outline of future therapeutic options.Keywords
This publication has 82 references indexed in Scilit:
- Characterization of recombinant human C1 inhibitor secreted in milk of transgenic rabbitsJournal of Biotechnology, 2012
- C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks - final results of the I.M.P.A.C.T.2 studyAllergy, 2011
- Home therapy with intravenous human C1‐inhibitor in children and adolescents with hereditary angioedemaTransfusion, 2011
- Hereditary Angioedema in ChildhoodPediatric Drugs, 2010
- 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedemaAllergy, Asthma & Clinical Immunology, 2010
- HAE international home therapy consensus documentAllergy, Asthma & Clinical Immunology, 2010
- On demand treatment and home therapy of hereditary angioedema in Germany - the Frankfurt experienceAllergy, Asthma & Clinical Immunology, 2010
- Pediatric hereditary angioedema due to C1-inhibitor deficiencyAllergy, Asthma & Clinical Immunology, 2010
- Oxandrolone treatment of childhood hereditary angioedemaAnnals of Allergy, Asthma & Immunology, 2004
- Altered C1 Inhibitor Genes in Type I Hereditary AngioedemaNew England Journal of Medicine, 1987